Note 3 - Acquisition of Astero Bio Corporation (Tables)

6 Months Ended

Jun. 30, 2019

Notes Tables

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Cash consideration	$	12,521
Contingent consideration		1,931
Working capital adjustment		(71	)
Total consideration transferred	$	14,381

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Cash and cash equivalents	$	12
Accounts receivable		154
Inventory		456
Customer relationships		160
Tradenames		470
Developed technology		3,920
Goodwill		9,524
Other assets		100
Accounts Payable		(251	)
Other liabilities		(164	)
Fair value of net assets acquired	$	14,381

	Estimated Fair Value		Estimated Useful Life (Years)
Customer relationships	$	160			4
Tradenames		470			9
Developed technologies		3,920		5	–	9
Total identifiable intangible assets	$	4,550

Business Acquisition, Pro Forma Information [Table Text Block]

	Six Months Ended June 30,
(In thousands)	2019		2018
Total revenue	$	12,681	$	9,016
Net income attributable to common stockholders	$	801	$	258
Earnings per share:
Basic	$	0.04	$	0.02
Diluted	$	0.03	$	0.01